top of page
gradientForSurfBreak.png

Item List

PR Newswire
Invitae Divests Ciitizen Health Data Platform and Implements Further Cost Cuts

Invitae (NYSE: NVTA), a leading medical genetics company, today announced strategic changes to streamline operations and reduce operating cash burn. The company has divested the assets of Ciitizen and announced strategic cost cuts, which will include a workforce reduction and other operating expense reductions.

Recent Posts

Portfolio Company

Carlsmed.png

Marigold Health Secures $11m in Series A Funding to Expand Peer Support
...

Busineswire

Portfolio Company

Carlsmed.png

Materna Medical Launches Groundbreaking Virtual Clinical Trial Evaluating Treatm ...

Yahoo Finance

Portfolio Company

Carlsmed.png


Clarified Precision Medicine, xCures Partner to Improve Clinical Decision Suppo ...

Precision Medicine Online

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page